Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients

American Journal of Case Reports ◽

10.12659/ajcr.908649 ◽

2018 ◽

Vol 19 ◽

pp. 505-511 ◽

Author(s):

Erica S. Tarabadkar ◽

Hannah Thomas ◽

Astrid Blom ◽

Upendra Parvathaneni ◽

Thomas Olencki ◽

...

Keyword(s):

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Merkel Cell Carcinoma ◽

Clinical Benefit ◽

Kinase Inhibitors ◽

Case Series ◽

Download Full-text

Faculty Opinions recommendation of Clinical benefit from tyrosine kinase inhibitors in metastatic Merkel cell carcinoma: a case series of 5 patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733135241.793567573 ◽

2019 ◽

Author(s):

Siegrid Yu

Keyword(s):

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Merkel Cell Carcinoma ◽

Clinical Benefit ◽

Kinase Inhibitors ◽

Case Series ◽

Download Full-text

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

Therapeutic Advances in Urology ◽

10.1177/17562872211029784 ◽

2021 ◽

Vol 13 ◽

pp. 175628722110297

Author(s):

Giandomenico Roviello ◽

Sebastiano Buti ◽

Carlo Cattrini ◽

Alessia Mennitto ◽

Carlo Messina ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Line Treatment ◽

Increased Risk ◽

First Line Treatment

Download Full-text

Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors

OncoTargets and Therapy ◽

10.2147/ott.s45872 ◽

2013 ◽

pp. 679 ◽

Author(s):

Daniel Cho

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Prognostic Biomarkers ◽

Advanced Renal Cell Carcinoma

Download Full-text

Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

European Urology ◽

10.1016/j.eururo.2008.10.021 ◽

2009 ◽

Vol 55 (6) ◽

pp. 1430-1439 ◽

Author(s):

Manfred Johannsen ◽

Anne Flörcken ◽

Axel Bex ◽

Jan Roigas ◽

Marco Cosentino ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Retrospective Analysis ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Complete Response ◽

Response To Treatment

Download Full-text

Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.10.002 ◽

2015 ◽

Vol 13 (4) ◽

pp. 280-286 ◽

Author(s):

Andreas Nearchou ◽

Antonis Valachis ◽

Pehr Lind ◽

Olof Akre ◽

Per Sandström

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Predictive Marker

Download Full-text

Additional Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Renal Cell Carcinoma ◽

10.1007/978-1-59745-332-5_10 ◽

2009 ◽

pp. 189-193

Author(s):

Brian I. Rini

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors

Download Full-text

PD57-08 TUMORAL CD8+ T CELLS CORRELATE WITH FAVORABLE OUTCOME IN METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS

The Journal of Urology ◽

10.1016/j.juro.2018.02.2652 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Jiajun Wang ◽

Li Liu ◽

Wei Xi ◽

Jiejie Xu ◽

Jianming Guo

Keyword(s):

Renal Cell Carcinoma ◽

T Cells ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Cd8 T Cells ◽

Kinase Inhibitors ◽

Favorable Outcome

Download Full-text

Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma

OncoImmunology ◽

10.1080/2162402x.2018.1515611 ◽

2018 ◽

Vol 8 (1) ◽

pp. e1515611

Author(s):

Jiajun Wang ◽

Li Liu ◽

Qi Bai ◽

Chenzhang Ou ◽

Ying Xiong ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Therapeutic Benefit

Download Full-text

Second-Generation Tyrosine Kinase Inhibitors (Pazopanib) in Renal Cell Carcinoma: Current Status

Renal Cell Carcinoma ◽

10.1007/978-1-4939-1622-1_9 ◽

2014 ◽

pp. 207-216

Author(s):

Linda Cerbone ◽

Cora N. Sternberg

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Second Generation ◽

Kinase Inhibitors ◽

Download Full-text

Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma

Annals of Oncology ◽

10.1093/annonc/mdy469 ◽

2019 ◽

Vol 30 (1) ◽

pp. 150-151

Author(s):

S.V. Lightowlers ◽

B. Greef ◽

T. Eisen ◽

A. Matakidou ◽

K. Fife ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors

Download Full-text